Skip to content
Screener

Celcuity CELC Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.4×+0.1×
Gilead Sciences logo
Gilead SciencesGILD
1.3×0.0×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
18.3×-2.7×
Immunome logo
ImmunomeIMNM
21.7×+11.2×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
16.3×+4.3×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The source filing: Celcuity’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180

FAQ

What is Celcuity's current ratio?
Celcuity (CELC) reported current ratio of 12.3× in Q1 2026.
How has Celcuity's current ratio changed year-over-year?
Celcuity's current ratio increased by 86.3% year-over-year, from 6.6× to 12.3×.
What is the long-term trend for Celcuity's current ratio?
Over 5 years (2020 to 2025), Celcuity's current ratio has grown at a 0.5% compound annual growth rate (CAGR), from 10.3× to 10.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Celcuity's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude